NCT04963699View on ClinicalTrials.gov

The Study of NT-proBNP Combined With HS-cTnT in Evaluating the Prognosis of Sepsis

CompletedOBSERVATIONAL

Enrollment

80

Participants

Timeline

Start Date

May 26, 2021

Primary Completion Date

June 2, 2021

Study Completion Date

June 9, 2021

Conditions

Sepsis

Trial Locations (1)

310000

Roche 601 Biochemical Immunoassay Instrument, Hangzhou

All Listed Sponsors

lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER